Krishnan Nandabalan Bio Xcel Therapeutics, Inc. (BTAI) insider trading activity

BTAI Quotes by TradingView

Krishnan Nandabalan is Director of BioXcel Therapeutics, Inc.. Currently has a direct ownership of 0 shares of BTAI, which is worth approximately $0. The most recent transaction as insider was on Apr 06, 2023, when has been sold 60,000 shares (Common Stock) at a price of $17.32 per share, resulting in proceeds of $1,039,200. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Krishnan Nandabalan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 06 2023
SELL
Open market or private sale
$1,039,200 $17.32 p/Share
60,000 Reduced 100.0%
0 Common Stock
Apr 06 2023
BUY
Exercise of conversion of derivative security
$24,600 $0.41 p/Share
60,000 Added 50.0%
60,000 Common Stock
Jan 05 2023
SELL
Open market or private sale
$585,868 $22.63 p/Share
25,889 Reduced 100.0%
0 Common Stock
Jan 05 2023
BUY
Exercise of conversion of derivative security
$10,614 $0.41 p/Share
25,889 Added 50.0%
25,889 Common Stock
Jan 04 2023
SELL
Open market or private sale
$747,030 $21.9 p/Share
34,111 Reduced 100.0%
0 Common Stock
Jan 04 2023
BUY
Exercise of conversion of derivative security
$13,985 $0.41 p/Share
34,111 Added 50.0%
34,111 Common Stock
Nov 11 2022
SELL
Open market or private sale
$488,250 $15.0 p/Share
32,550 Reduced 100.0%
0 Common Stock
Nov 11 2022
BUY
Exercise of conversion of derivative security
$13,345 $0.41 p/Share
32,550 Added 50.0%
32,550 Common Stock
Nov 10 2022
SELL
Open market or private sale
$411,750 $15.0 p/Share
27,450 Reduced 100.0%
0 Common Stock
Nov 10 2022
BUY
Exercise of conversion of derivative security
$11,254 $0.41 p/Share
27,450 Added 50.0%
27,450 Common Stock
Jul 24 2020
BUY
Other acquisition or disposition
$4,860,800 $60.76 p/Share
80,000 Added 50.0%
80,000 Common Stock
Apr 01 2019
SELL
Bona fide gift
-
1,000 Reduced 100.0%
0 Common Stock
KN

Krishnan Nandabalan

Director
New Haven, CT

Track Institutional and Insider Activities on BTAI

Follow BioXcel Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BTAI shares.

Notify only if

Insider Trading

Get notified when an Bio Xcel Therapeutics, Inc. insider buys or sells BTAI shares.

Notify only if

News

Receive news related to BioXcel Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BTAI